Table 2

Univariate and multivariate analyses of recurrence-free and overall survival

ParameterRecurrence-free survivalOverall survival
UnivariateMultivariateUnivariateMultivariate
HR (95% CI)P valueHR (95% CI)P valueHR (95% CI)PHR (95% CI)P value
SexMale10.26110.393
Female0.753 (0.459 to 1.235)0.809 (0.497 to 1.316)
Age (years)<5810.00110.0011<0.0011<0.001
≥582.298 (1.425 to 3.704)2.297 (1.421 to 3.712)4.243 (2.448 to 7.354)4.243 (2.444 to 7.367)
HistologyWD/MD10.66510.614
PD/SRC0.904 (0.573 to 1.427)0.890 (0.567 to 1.398)
Lauren typeIntestinal10.99410.612
Diffuse0.998 (0.638 to 1.561)0.891 (0.572 to 1.390)
T stagepT1-21<0.00110.0021<0.00110.003
pT3-44.870 (2.679 to 8.851)2.637 (1.410 to 4.931)3.465 (2.020 to 5.942)2.383 (1.342 to 4.232)
N stagepN01<0.0011<0.0011<0.00110.005
pN1-37.197 (3.587 to 14.440)4.644 (2.236 to 9.646)3.590 (2.069 to 6.232)2.318 (1.282 to 4.190)
Crohn-like lymphoid reactionScore 010.99110.820
Score 10.958 (0.505 to 1.816)0.823 (0.447 to 1.515)
Score 2–30.976 (0.508 to 1.873)0.863 (0.464 to 1.604)
Peritumoral lymphoid reactionScore 010.43910.356
Score 10.692 (0.393 to 1.218)0.698 (0.390 to 1.250)
Score 2–30.758 (0.409 to 1.404)0.947 (0.516 to 1.737)
Intratumoral lymphoid reactionScore 010.03410.07510.02410.078
Score 10.477 (0.235 to 0.968)0.554 (0.270 to 1.134)0.468 (0.238 to 0.921)0.586 (0.294 to 1.168)
Score 2–30.336 (0.147 to 0.768)0.375 (0.161 to 0.874)0.332 (0.149 to 0.740)0.388 (0.170 to 0.883)
Overall lymphoid reactionScore 0–210.58810.675
Score 3–60.784 (0.467 to 1.315)0.792 (0.472 to 1.330)
Score 7–90.691 (0.278 to 1.722)0.814 (0.344 to 1.927)
HEV densityLow1<0.00110.0011<0.00110.020
High0.281 (0.167 to 0.473)0.412 (0.241 to 0.705)0.382 (0.235 to 0.623)0.547 (0.329 to 0.909)
  • .HEV, high endothelial venule; MD, moderate differentiated; OS, overall survival; PD, poorly differentiated; SRC, signet ring cell; WD, well differentiated.